A blood test measuring IgG and IgM antibodies to Borrelia, the bacteria behind Lyme disease, used as an initial check when Lyme disease is suspected alongside your symptoms and history.
2 biomarkers as listed by Blue Horizon Medicals.
IgG and IgM antibodies to Borrelia are markers your immune system produces after exposure to the bacteria behind Lyme disease. Testing for both together is a standard starting point when Lyme disease is suspected, though as the provider notes, a positive result would need confirmatory testing and a negative one does not rule the condition out; your symptoms and history matter as much as the result itself.
With two biomarkers covering both antibody types, this test scores strongly for clinical depth against the immunity tests we track. It is also priced below the typical range for similarly sized immunity tests, which helps its overall value. Collection convenience is more limited, since it needs a venous blood draw at a clinic or through a home nurse visit rather than an at-home kit, and results take around 5 days. The listing sets out a short description, the biomarker list, turnaround and collection options clearly, though it does not describe the report format.
Blue Horizon Medicals has traded since 2009, uses UKAS ISO 15189 partner labs, and has a Trustpilot score of 4.2 from 395 reviews. Results are reviewed by a doctor before you see them.
This suits you if you have symptoms or a history that make Lyme disease a reasonable concern and you want an initial antibody check alongside seeing a GP, since interpreting the result properly depends on your clinical picture. It is not suitable as a stand-alone way of confirming or excluding Lyme disease, and the provider notes that Bartonella infection can cause similar symptoms and coexist with Borrelia, so you may want to discuss testing for that too with a clinician. We do not have peer tests logged in this comparison group, so we cannot compare it directly with other providers' Lyme antibody tests.
A healthcare professional takes a venous blood sample at a clinic or during a home nurse visit; there is no at-home finger-prick option for this test. The lab tests the sample for IgG and IgM antibodies to Borrelia, and a doctor reviews the result before it is released to you, typically within 5 days.
Lyme disease is the reason most people order this test, which checks IgG and IgM antibodies to Borrelia at £99.25, below the median for similarly sized immunity tests we track. It needs a venous draw with no at-home option, and results are doctor-reviewed within 5 days. As the provider notes, a positive result needs confirmatory testing and a negative one does not rule Lyme disease out.
The listing publishes a short description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
2 biomarkers, placing it in the 76th percentile of immunity tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, slower than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£99.25 against a median of £124.63 for the 88 similarly sized immunity tests we track (-20%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
